US 11685744
CDK inhibitors and their use as pharmaceuticals
granted A61KA61K31/4188A61K31/4196
Quick answer
US patent 11685744 (CDK inhibitors and their use as pharmaceuticals) held by Prelude Therapeutics, Incorporated expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K31/4188, A61K31/4196, A61K31/506, A61K31/5355